Daito Pharmaceutical Co., Ltd.

Form 483FOIA Uncovered

Toyama, -, JapanFEI 3002806779Issued December 19, 2023

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3002806779.

Observations2

Issue DateDecember 19, 2023

StatusNo Warning Letter

Related Inspections4

Establishment Details

Firm: Daito Pharmaceutical Co., Ltd.
Location: Toyama, -, Japan
FEI Number: 3002806779
Product Type: Drugs
Issue Date: December 19, 2023
Country: Japan

Inspection History, 2011 to 2023

VAI3

OAI1

VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Daito Pharmaceutical Co., Ltd. FDA Form 483, Toyama, December 19, 2023